Request for Covid-19 Impact Assessment of this Report
The United States Human Vaccination market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Human Vaccination market, reaching US$ million by the year 2028. As for the Europe Human Vaccination landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Human Vaccination players cover GSK, Merck, Sanofi, and Sinovac, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Vaccination market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Inactivated Vaccine
Live-attenuated Vaccine
mRNA Vaccine
Conjugate Vaccine
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Government Institution
Private Sector
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Pfizer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Vaccination Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Human Vaccination by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Human Vaccination by Country/Region, 2017, 2022 & 2028
2.2 Human Vaccination Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Live-attenuated Vaccine
2.2.3 mRNA Vaccine
2.2.4 Conjugate Vaccine
2.2.5 Other
2.3 Human Vaccination Sales by Type
2.3.1 Global Human Vaccination Sales Market Share by Type (2017-2022)
2.3.2 Global Human Vaccination Revenue and Market Share by Type (2017-2022)
2.3.3 Global Human Vaccination Sale Price by Type (2017-2022)
2.4 Human Vaccination Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 Human Vaccination Sales by Application
2.5.1 Global Human Vaccination Sale Market Share by Application (2017-2022)
2.5.2 Global Human Vaccination Revenue and Market Share by Application (2017-2022)
2.5.3 Global Human Vaccination Sale Price by Application (2017-2022)
3 Global Human Vaccination by Company
3.1 Global Human Vaccination Breakdown Data by Company
3.1.1 Global Human Vaccination Annual Sales by Company (2020-2022)
3.1.2 Global Human Vaccination Sales Market Share by Company (2020-2022)
3.2 Global Human Vaccination Annual Revenue by Company (2020-2022)
3.2.1 Global Human Vaccination Revenue by Company (2020-2022)
3.2.2 Global Human Vaccination Revenue Market Share by Company (2020-2022)
3.3 Global Human Vaccination Sale Price by Company
3.4 Key Manufacturers Human Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Vaccination Product Location Distribution
3.4.2 Players Human Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Vaccination by Geographic Region
4.1 World Historic Human Vaccination Market Size by Geographic Region (2017-2022)
4.1.1 Global Human Vaccination Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Human Vaccination Annual Revenue by Geographic Region
4.2 World Historic Human Vaccination Market Size by Country/Region (2017-2022)
4.2.1 Global Human Vaccination Annual Sales by Country/Region (2017-2022)
4.2.2 Global Human Vaccination Annual Revenue by Country/Region
4.3 Americas Human Vaccination Sales Growth
4.4 APAC Human Vaccination Sales Growth
4.5 Europe Human Vaccination Sales Growth
4.6 Middle East & Africa Human Vaccination Sales Growth
5 Americas
5.1 Americas Human Vaccination Sales by Country
5.1.1 Americas Human Vaccination Sales by Country (2017-2022)
5.1.2 Americas Human Vaccination Revenue by Country (2017-2022)
5.2 Americas Human Vaccination Sales by Type
5.3 Americas Human Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Vaccination Sales by Region
6.1.1 APAC Human Vaccination Sales by Region (2017-2022)
6.1.2 APAC Human Vaccination Revenue by Region (2017-2022)
6.2 APAC Human Vaccination Sales by Type
6.3 APAC Human Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Vaccination by Country
7.1.1 Europe Human Vaccination Sales by Country (2017-2022)
7.1.2 Europe Human Vaccination Revenue by Country (2017-2022)
7.2 Europe Human Vaccination Sales by Type
7.3 Europe Human Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Vaccination by Country
8.1.1 Middle East & Africa Human Vaccination Sales by Country (2017-2022)
8.1.2 Middle East & Africa Human Vaccination Revenue by Country (2017-2022)
8.2 Middle East & Africa Human Vaccination Sales by Type
8.3 Middle East & Africa Human Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Vaccination
10.3 Manufacturing Process Analysis of Human Vaccination
10.4 Industry Chain Structure of Human Vaccination
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Vaccination Distributors
11.3 Human Vaccination Customer
12 World Forecast Review for Human Vaccination by Geographic Region
12.1 Global Human Vaccination Market Size Forecast by Region
12.1.1 Global Human Vaccination Forecast by Region (2023-2028)
12.1.2 Global Human Vaccination Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Vaccination Forecast by Type
12.7 Global Human Vaccination Forecast by Application
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Human Vaccination Product Offered
13.1.3 GSK Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Human Vaccination Product Offered
13.2.3 Merck Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Human Vaccination Product Offered
13.3.3 Sanofi Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Sinovac
13.4.1 Sinovac Company Information
13.4.2 Sinovac Human Vaccination Product Offered
13.4.3 Sinovac Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sinovac Main Business Overview
13.4.5 Sinovac Latest Developments
13.5 Zhejiang Pukang
13.5.1 Zhejiang Pukang Company Information
13.5.2 Zhejiang Pukang Human Vaccination Product Offered
13.5.3 Zhejiang Pukang Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Zhejiang Pukang Main Business Overview
13.5.5 Zhejiang Pukang Latest Developments
13.6 Changchun Institute of Biological
13.6.1 Changchun Institute of Biological Company Information
13.6.2 Changchun Institute of Biological Human Vaccination Product Offered
13.6.3 Changchun Institute of Biological Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Changchun Institute of Biological Main Business Overview
13.6.5 Changchun Institute of Biological Latest Developments
13.7 KM Biologics
13.7.1 KM Biologics Company Information
13.7.2 KM Biologics Human Vaccination Product Offered
13.7.3 KM Biologics Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 KM Biologics Main Business Overview
13.7.5 KM Biologics Latest Developments
13.8 IMBCAMS
13.8.1 IMBCAMS Company Information
13.8.2 IMBCAMS Human Vaccination Product Offered
13.8.3 IMBCAMS Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 IMBCAMS Main Business Overview
13.8.5 IMBCAMS Latest Developments
13.9 Convac
13.9.1 Convac Company Information
13.9.2 Convac Human Vaccination Product Offered
13.9.3 Convac Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Convac Main Business Overview
13.9.5 Convac Latest Developments
13.10 NCPC
13.10.1 NCPC Company Information
13.10.2 NCPC Human Vaccination Product Offered
13.10.3 NCPC Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 NCPC Main Business Overview
13.10.5 NCPC Latest Developments
13.11 Bio Kangtai
13.11.1 Bio Kangtai Company Information
13.11.2 Bio Kangtai Human Vaccination Product Offered
13.11.3 Bio Kangtai Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Bio Kangtai Main Business Overview
13.11.5 Bio Kangtai Latest Developments
13.12 Dynavax
13.12.1 Dynavax Company Information
13.12.2 Dynavax Human Vaccination Product Offered
13.12.3 Dynavax Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Dynavax Main Business Overview
13.12.5 Dynavax Latest Developments
13.13 Hissen
13.13.1 Hissen Company Information
13.13.2 Hissen Human Vaccination Product Offered
13.13.3 Hissen Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Hissen Main Business Overview
13.13.5 Hissen Latest Developments
13.14 KM Biologics
13.14.1 KM Biologics Company Information
13.14.2 KM Biologics Human Vaccination Product Offered
13.14.3 KM Biologics Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 KM Biologics Main Business Overview
13.14.5 KM Biologics Latest Developments
13.15 LG Life Sciences
13.15.1 LG Life Sciences Company Information
13.15.2 LG Life Sciences Human Vaccination Product Offered
13.15.3 LG Life Sciences Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 LG Life Sciences Main Business Overview
13.15.5 LG Life Sciences Latest Developments
13.16 Serum Institute
13.16.1 Serum Institute Company Information
13.16.2 Serum Institute Human Vaccination Product Offered
13.16.3 Serum Institute Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Serum Institute Main Business Overview
13.16.5 Serum Institute Latest Developments
13.17 Pfizer
13.17.1 Pfizer Company Information
13.17.2 Pfizer Human Vaccination Product Offered
13.17.3 Pfizer Human Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Pfizer Main Business Overview
13.17.5 Pfizer Latest Developments
14 Research Findings and Conclusion
Table 1. Human Vaccination Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Human Vaccination Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Live-attenuated Vaccine
Table 5. Major Players of mRNA Vaccine
Table 6. Major Players of Conjugate Vaccine
Table 7. Major Players of Other
Table 8. Global Human Vaccination Sales by Type (2017-2022) & (Units)
Table 9. Global Human Vaccination Sales Market Share by Type (2017-2022)
Table 10. Global Human Vaccination Revenue by Type (2017-2022) & ($ million)
Table 11. Global Human Vaccination Revenue Market Share by Type (2017-2022)
Table 12. Global Human Vaccination Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Human Vaccination Sales by Application (2017-2022) & (Units)
Table 14. Global Human Vaccination Sales Market Share by Application (2017-2022)
Table 15. Global Human Vaccination Revenue by Application (2017-2022)
Table 16. Global Human Vaccination Revenue Market Share by Application (2017-2022)
Table 17. Global Human Vaccination Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Human Vaccination Sales by Company (2020-2022) & (Units)
Table 19. Global Human Vaccination Sales Market Share by Company (2020-2022)
Table 20. Global Human Vaccination Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Human Vaccination Revenue Market Share by Company (2020-2022)
Table 22. Global Human Vaccination Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Human Vaccination Producing Area Distribution and Sales Area
Table 24. Players Human Vaccination Products Offered
Table 25. Human Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Human Vaccination Sales by Geographic Region (2017-2022) & (Units)
Table 29. Global Human Vaccination Sales Market Share Geographic Region (2017-2022)
Table 30. Global Human Vaccination Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Human Vaccination Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Human Vaccination Sales by Country/Region (2017-2022) & (Units)
Table 33. Global Human Vaccination Sales Market Share by Country/Region (2017-2022)
Table 34. Global Human Vaccination Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Human Vaccination Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Human Vaccination Sales by Country (2017-2022) & (Units)
Table 37. Americas Human Vaccination Sales Market Share by Country (2017-2022)
Table 38. Americas Human Vaccination Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Human Vaccination Revenue Market Share by Country (2017-2022)
Table 40. Americas Human Vaccination Sales by Type (2017-2022) & (Units)
Table 41. Americas Human Vaccination Sales Market Share by Type (2017-2022)
Table 42. Americas Human Vaccination Sales by Application (2017-2022) & (Units)
Table 43. Americas Human Vaccination Sales Market Share by Application (2017-2022)
Table 44. APAC Human Vaccination Sales by Region (2017-2022) & (Units)
Table 45. APAC Human Vaccination Sales Market Share by Region (2017-2022)
Table 46. APAC Human Vaccination Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Human Vaccination Revenue Market Share by Region (2017-2022)
Table 48. APAC Human Vaccination Sales by Type (2017-2022) & (Units)
Table 49. APAC Human Vaccination Sales Market Share by Type (2017-2022)
Table 50. APAC Human Vaccination Sales by Application (2017-2022) & (Units)
Table 51. APAC Human Vaccination Sales Market Share by Application (2017-2022)
Table 52. Europe Human Vaccination Sales by Country (2017-2022) & (Units)
Table 53. Europe Human Vaccination Sales Market Share by Country (2017-2022)
Table 54. Europe Human Vaccination Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Human Vaccination Revenue Market Share by Country (2017-2022)
Table 56. Europe Human Vaccination Sales by Type (2017-2022) & (Units)
Table 57. Europe Human Vaccination Sales Market Share by Type (2017-2022)
Table 58. Europe Human Vaccination Sales by Application (2017-2022) & (Units)
Table 59. Europe Human Vaccination Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Human Vaccination Sales by Country (2017-2022) & (Units)
Table 61. Middle East & Africa Human Vaccination Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Human Vaccination Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Human Vaccination Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Human Vaccination Sales by Type (2017-2022) & (Units)
Table 65. Middle East & Africa Human Vaccination Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Human Vaccination Sales by Application (2017-2022) & (Units)
Table 67. Middle East & Africa Human Vaccination Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Human Vaccination
Table 69. Key Market Challenges & Risks of Human Vaccination
Table 70. Key Industry Trends of Human Vaccination
Table 71. Human Vaccination Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Human Vaccination Distributors List
Table 74. Human Vaccination Customer List
Table 75. Global Human Vaccination Sales Forecast by Region (2023-2028) & (Units)
Table 76. Global Human Vaccination Sales Market Forecast by Region
Table 77. Global Human Vaccination Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Human Vaccination Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Human Vaccination Sales Forecast by Country (2023-2028) & (Units)
Table 80. Americas Human Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Human Vaccination Sales Forecast by Region (2023-2028) & (Units)
Table 82. APAC Human Vaccination Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Human Vaccination Sales Forecast by Country (2023-2028) & (Units)
Table 84. Europe Human Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Human Vaccination Sales Forecast by Country (2023-2028) & (Units)
Table 86. Middle East & Africa Human Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Human Vaccination Sales Forecast by Type (2023-2028) & (Units)
Table 88. Global Human Vaccination Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Human Vaccination Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Human Vaccination Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Human Vaccination Sales Forecast by Application (2023-2028) & (Units)
Table 92. Global Human Vaccination Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Human Vaccination Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Human Vaccination Revenue Market Share Forecast by Application (2023-2028)
Table 95. GSK Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 96. GSK Human Vaccination Product Offered
Table 97. GSK Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. GSK Main Business
Table 99. GSK Latest Developments
Table 100. Merck Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 101. Merck Human Vaccination Product Offered
Table 102. Merck Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Merck Main Business
Table 104. Merck Latest Developments
Table 105. Sanofi Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 106. Sanofi Human Vaccination Product Offered
Table 107. Sanofi Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Sanofi Main Business
Table 109. Sanofi Latest Developments
Table 110. Sinovac Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 111. Sinovac Human Vaccination Product Offered
Table 112. Sinovac Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Sinovac Main Business
Table 114. Sinovac Latest Developments
Table 115. Zhejiang Pukang Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 116. Zhejiang Pukang Human Vaccination Product Offered
Table 117. Zhejiang Pukang Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Zhejiang Pukang Main Business
Table 119. Zhejiang Pukang Latest Developments
Table 120. Changchun Institute of Biological Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 121. Changchun Institute of Biological Human Vaccination Product Offered
Table 122. Changchun Institute of Biological Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Changchun Institute of Biological Main Business
Table 124. Changchun Institute of Biological Latest Developments
Table 125. KM Biologics Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 126. KM Biologics Human Vaccination Product Offered
Table 127. KM Biologics Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. KM Biologics Main Business
Table 129. KM Biologics Latest Developments
Table 130. IMBCAMS Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 131. IMBCAMS Human Vaccination Product Offered
Table 132. IMBCAMS Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. IMBCAMS Main Business
Table 134. IMBCAMS Latest Developments
Table 135. Convac Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 136. Convac Human Vaccination Product Offered
Table 137. Convac Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. Convac Main Business
Table 139. Convac Latest Developments
Table 140. NCPC Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 141. NCPC Human Vaccination Product Offered
Table 142. NCPC Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. NCPC Main Business
Table 144. NCPC Latest Developments
Table 145. Bio Kangtai Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 146. Bio Kangtai Human Vaccination Product Offered
Table 147. Bio Kangtai Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 148. Bio Kangtai Main Business
Table 149. Bio Kangtai Latest Developments
Table 150. Dynavax Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 151. Dynavax Human Vaccination Product Offered
Table 152. Dynavax Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 153. Dynavax Main Business
Table 154. Dynavax Latest Developments
Table 155. Hissen Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 156. Hissen Human Vaccination Product Offered
Table 157. Hissen Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 158. Hissen Main Business
Table 159. Hissen Latest Developments
Table 160. KM Biologics Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 161. KM Biologics Human Vaccination Product Offered
Table 162. KM Biologics Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 163. KM Biologics Main Business
Table 164. KM Biologics Latest Developments
Table 165. LG Life Sciences Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 166. LG Life Sciences Human Vaccination Product Offered
Table 167. LG Life Sciences Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 168. LG Life Sciences Main Business
Table 169. LG Life Sciences Latest Developments
Table 170. Serum Institute Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 171. Serum Institute Human Vaccination Product Offered
Table 172. Serum Institute Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 173. Serum Institute Main Business
Table 174. Serum Institute Latest Developments
Table 175. Pfizer Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 176. Pfizer Human Vaccination Product Offered
Table 177. Pfizer Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 178. Pfizer Main Business
Table 179. Pfizer Latest Developments
List of Figures
Figure 1. Picture of Human Vaccination
Figure 2. Human Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Vaccination Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Human Vaccination Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Human Vaccination Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Inactivated Vaccine
Figure 10. Product Picture of Live-attenuated Vaccine
Figure 11. Product Picture of mRNA Vaccine
Figure 12. Product Picture of Conjugate Vaccine
Figure 13. Product Picture of Other
Figure 14. Global Human Vaccination Sales Market Share by Type in 2021
Figure 15. Global Human Vaccination Revenue Market Share by Type (2017-2022)
Figure 16. Human Vaccination Consumed in Government Institution
Figure 17. Global Human Vaccination Market: Government Institution (2017-2022) & (Units)
Figure 18. Human Vaccination Consumed in Private Sector
Figure 19. Global Human Vaccination Market: Private Sector (2017-2022) & (Units)
Figure 20. Human Vaccination Consumed in Other
Figure 21. Global Human Vaccination Market: Other (2017-2022) & (Units)
Figure 22. Global Human Vaccination Sales Market Share by Application (2017-2022)
Figure 23. Global Human Vaccination Revenue Market Share by Application in 2021
Figure 24. Human Vaccination Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Human Vaccination Revenue Market Share by Company in 2021
Figure 26. Global Human Vaccination Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Human Vaccination Revenue Market Share by Geographic Region in 2021
Figure 28. Global Human Vaccination Sales Market Share by Region (2017-2022)
Figure 29. Global Human Vaccination Revenue Market Share by Country/Region in 2021
Figure 30. Americas Human Vaccination Sales 2017-2022 (Units)
Figure 31. Americas Human Vaccination Revenue 2017-2022 ($ Millions)
Figure 32. APAC Human Vaccination Sales 2017-2022 (Units)
Figure 33. APAC Human Vaccination Revenue 2017-2022 ($ Millions)
Figure 34. Europe Human Vaccination Sales 2017-2022 (Units)
Figure 35. Europe Human Vaccination Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Human Vaccination Sales 2017-2022 (Units)
Figure 37. Middle East & Africa Human Vaccination Revenue 2017-2022 ($ Millions)
Figure 38. Americas Human Vaccination Sales Market Share by Country in 2021
Figure 39. Americas Human Vaccination Revenue Market Share by Country in 2021
Figure 40. United States Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Human Vaccination Sales Market Share by Region in 2021
Figure 45. APAC Human Vaccination Revenue Market Share by Regions in 2021
Figure 46. China Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Human Vaccination Sales Market Share by Country in 2021
Figure 53. Europe Human Vaccination Revenue Market Share by Country in 2021
Figure 54. Germany Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Human Vaccination Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Human Vaccination Revenue Market Share by Country in 2021
Figure 61. Egypt Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Human Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Human Vaccination in 2021
Figure 67. Manufacturing Process Analysis of Human Vaccination
Figure 68. Industry Chain Structure of Human Vaccination
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...